Product Description
Overall, the global peripheral intravascular ultrasound (IVUS) market was valued at over $197 million in 2023. This is expected to increase over the forecast period at a CAGR of 7.6% to reach $330 million.
Throughout this medical market research, we analyzed over 5 peripheral IVUS companies across 7 continents and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts. The full report suite on the global market for peripheral IVUSs extends its projections up to the year 2030, thereby providing a comprehensive and anticipatory understanding of the market trends and trajectories for the given period.
DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- Forecasts Until 2030, and Historical Data to 2020
- Market Drivers & Limiters for Each Segment
- Competitive Analysis with Market Shares for Each Segment
- Recent Mergers & Acquisitions
- COVID19 Impact
- Disease Overviews and Demographic Information
- Company Profiles, Product Portfolios and SWOT for Top Competitors
Global Peripheral IVUS Market Insights
A persistent trend in the global IVUS market involves advancing high-definition imaging technologies and miniaturized catheter systems. These innovations enhance vessel structure visualization and navigation during interventional procedures, meeting the increasing demand for real-time, precise intravascular imaging. This enables clinicians to make informed decisions, optimize stent placements, and improve procedural outcomes, especially in complex cases.
Global Peripheral IVUS Market Share Insights
- Philips leads the peripheral IVUS catheter market with an extensive portfolio, including models like Visions® PV .018, Visions® PV.035, Visions® PV .014P, and Visions® PV .014P RX. The Eagle Eye Platinum and Eagle Eye Platinum ST IVUS catheters are versatile for both coronary and peripheral procedures, compatible with Philips’ Core® and Core® Mobile IVUS consoles.
- Boston Scientific ranks second in the 2023 peripheral IVUS catheter market with its OptiCross18® peripheral IVUS catheter compatible with iLab® and POLARIS™ systems. The company excels in peripheral arterial disease (PAD) indications with its comprehensive portfolio.
Market Segmentation Summary
- Peripheral IVUS Market
Global Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam) Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2023 |
| Forecast | 2024-2030 |
| Historical Data | 2020-2023 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
